Literature DB >> 22785245

Lyophilized aspirin with trehalose may decrease the incidence of gastric injuries in healthy dogs.

Lee-Shuan Lin1, Yuko Kayasuga, Nobuyuki Shimohata, Hiroyuki Kamata, Shigeki Suzuki, Ryosuke Echigo, Manabu Mochizuki, Ung-Il Chung, Nobuo Sasaki.   

Abstract

Trehalose has several novel anti-inflammatory and cell-protective functions. We hypothesized that lyophilized aspirin/trehalose could decrease the severity of aspirin-induced gastropathy. Thirteen dogs were assigned into aspirin, lyophilized aspirin/trehalose, and control groups, and the gastric lesions were assessed on gastroscopy with the modified Lanza scale. Another 6 dogs were used to measure the plasma aspirin concentration by high-performance liquid chromatography after aspirin or lyophilized aspirin/trehalose administration. The results indicated that lyophilized aspirin/trehalose induced less gastric ulceration than aspirin despite maintaining therapeutic concentrations of plasma aspirin in both the groups. Lyophilized aspirin/trehalose might be a solution to decrease aspirin-induced gastropathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785245     DOI: 10.1292/jvms.12-0109

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  2 in total

1.  Co-lyophilized Aspirin with Trehalose Causes Less Injury to Human Gastric Cells and Gastric Mucosa of Rats.

Authors:  Lee-Shuan Lin; Yuko Kayasuga-Kariya; Shugo Nakamura; Nobuyuki Shimohata; Takamasa Sakai; Ayano Fujisawa; Yuki Akagi; Shigeki Suzuki; Ung-Il Chung; Nobuo Sasaki; Manabu Mochizuki
Journal:  Dig Dis Sci       Date:  2016-05-31       Impact factor: 3.199

2.  Dermal cell damage induced by topical application of non-steroidal anti-inflammatory drugs is suppressed by trehalose co-lyophilization in ex vivo analysis.

Authors:  Yuko Kayasuga-Kariya; Shintaroh Iwanaga; Ayano Fujisawa; Lee-Shuan Lin; Shigeki Suzuki; Ung-Il Chung; Nobuo Sasaki; Nobuyuki Shimohata; Manabu Mochizuki
Journal:  J Vet Med Sci       Date:  2013-07-24       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.